Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12624000701527
ACTRN12624000701527
Recruiting
Phase 4

The efficacy of Botulinum Toxin A (BTA) as an Adjunct to Surgical Repair of Large Ventral Hernia in Adults, A Randomised Controlled Trial

Dr Mary Ann Johnson0 sites168 target enrollmentJune 4, 2024
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsMassive ventral herniaSurgery - Surgical techniquesOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonMusculoskeletal - Other muscular and skeletal disorders

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Massive ventral hernia
Sponsor
Dr Mary Ann Johnson
Enrollment
168
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 4, 2024
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Dr Mary Ann Johnson

Eligibility Criteria

Inclusion Criteria

  • •Is greater than and equal to 18 years of ages at enrolment
  • •Has a large ventral hernia that requires surgical repair as determined by attendance of the Hepatobiliary and Upper Gastrointestinal Surgical Clinic
  • •Ability to understand study information in English
  • •Provide a signed and dated informed consent form

Exclusion Criteria

  • •Emergency procedures
  • •Prisoners
  • •Hernia with defect greater than 14cm transversely or more than 50% loss of domain
  • •Known hypersensitivity to any ingredient in the formulation.
  • •Participants with myasthenia gravis or Eaton Lambert syndrome.
  • •Presence of infection at the proposed injection site(s).

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Analysis of efficacy of butulinum toxin type A treatment for compensatory hyperhidrosisCompensatory hyperhidrosis
JPRN-UMIN000004254Department of Dermatology Aichi Medical University school of Medicine10
Completed
Phase 2
Botulinum toxin for nocturnal bruxism.
ACTRN12618001430224Melbourne Health41
Completed
Not Applicable
Is neuromodulation with botulinum toxin type A an alternative treatment for chronic anal fissure?Chronic anal fissureDigestive System
ISRCTN90354265Hospital General Nuestra Señora del Prado49
Recruiting
Phase 3
Evaluation the effect of Botulinium toxin injection on improving symptoms in patients with diabetic neuropathy
IRCT20240116060710N1Shahid Beheshti University of Medical Sciences30
Not yet recruiting
Not Applicable
Assessment of Botulinum Toxin Type A in the Treatment of Hand Eczema
PACTR201704002194318Dermatology Department, Faculty of Medicine, University of Alexandria60